Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

NCT00606437

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Infectious Causes of Uveitis

NCT00676624

Conditions: Eye Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Glostrup Hospital Glostrup Municipality, Denmark

View Trial Details

Completed

Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma

NCT00392496

Conditions: Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Completed

Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00398112

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +16 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

NCT00802737

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: GSK Investigational Site Örebro, Sweden

GSK Investigational Site Stockholm, Sweden

View Trial Details

Completed

A Phase I/II Study of GX15-070MS in Untreated CLL

NCT00600964

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University of CA- San Diego La Jolla, California, United States

Lombardi Cancer Center Washington D.C., District of Columbia, United States

Milton S Hershey Medical Center Penn State Cancer Institute Hershey, Pennsylvania, United States

UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT00303953

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: Providence Hospital Mobile, Alabama, United States

University of Arizona Health Sciences Center Tucson, Arizona, United States

NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View all 123 locations

View Trial Details

Completed

Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma

NCT01130194

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Saint Louis University Cancer Center St Louis, Missouri, United States

View Trial Details

Completed

S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma

NCT01131221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

NCT00076349

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Alaska Cancer Research and Education Center Anchorage, Alaska, United States

Bay Area Cancer Research Group Concord, California, United States

Wilshire Oncology Medical Group La Verne, California, United States

USC/Kenneth Norris Jr. Cancer Hospital and Research Institute Los Angeles, California, United States

View all 34 locations

View Trial Details